Select Bibliography

Filter by any of these (after searching):

NCCTG-N08C9

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

N08C9 (Alliance) - A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - Int J Radiat Oncol Biol Phys - 2013

Abstract - Primary - Primary - Symptom Inter - NCCTG-N08C9

Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - INT J RADIAT BIOL - 2014

Abstract - Secondary - Primary - Symptom Inter - NCCTG-N08C9

Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASCO GI - J Clin Oncol - 2015

Abstract - Secondary - Primary - Symptom Inter - NCCTG-N08C9

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine vs Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Miller, Robert C. , Petereit, Daniel G. , Sloan, Jeff A. ... - - Int J Radiat Oncol Biol Phys - 2016

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N08C9